Pen Needles Market by Type, Needle Length, Therapy - Analysis & Global Forecast to 2019

  • ID: 3032078
  • Report
  • Region: Global
  • 169 Pages
  • Markets and Markets
1 of 6
The global pen needles market is expected to reach $2,105 million in 2019 from $1,283 million in 2014, growing at a CAGR of 10.4%.

FEATURED COMPANIES

  • Allison Medical, Inc.
  • Artsana S.P.A.
  • B. Braun Melsungen
  • Htl-Strefa S.A.
  • Novo Nordisk A/S
  • Owen Mumford, Ltd.
  • MORE
Pen Needles Market by Type (Standard and Safety), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, and 12mm), Therapy (Insulin, Glucagon-like peptide, Growth Hormones) - Analysis & Global Forecast to 2019

Over the years, the pen needles market has witnessed various technological advancements in order to cater to the growing demand of safety injections in the healthcare industry. These advancements have led to development of safety pen needles with an aim to reduce pain, increase comfort, and most importantly reduce needlestick injuries (NSIs).

The standard pen needles segment accounts for the largest share of the global pen needles market, by type, while 6mm pen needles accounted for the largest share of the pen needles market, by needle length. Insulin therapy accounted for major share of the pen needles market, by therapy in 2014.

Europe accounted for the largest share of the global pen needles market, followed by North America, Asia, and the Rest of the World (RoW). In the coming years, the pen needles market is expected to experience the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to serve as revenue pockets for pen needle manufacturers.

The global pen needles market is witnessing a high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (new product launches, acquisitions, and geographical expansions) to increase their market shares and to establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the pen needles market. The report analyzes pen needles products by type

- Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the pen needles market

- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various pen needles technologies across regions

- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the pen needles market

Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the pen needles market. Over the years, the pen needles market has witnessed various technological advancements in order to cater to the growing demand of safety injections in the healthcare industry. These advancements have led to development of safety pen needles with an aim to reduce pain, increase comfort, and most importantly reduce needlestick injuries (NSIs).

The standard pen needles segment accounts for the largest share of the global pen needles market, by type, while 6mm pen needles accounted for the largest share of the pen needles market, by needle length. Insulin therapy account for major share of the pen needles market, by therapy in 2014.

Europe accounted for the largest share of the global pen needles market, followed by North America, Asia, and the Rest of the World (RoW). In the coming years, the pen needles market is expected to experience the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to serve as revenue pockets for pen needle manufacturers.

The global pen needles market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (new product launches, acquisitions, and geographical expansions) to increase their market shares and to establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the pen needles market. The report analyzes pen needles products by type

- Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the pen needles market

- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various pen needles technologies across regions

- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the pen needles market

- Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the pen needles market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Allison Medical, Inc.
  • Artsana S.P.A.
  • B. Braun Melsungen
  • Htl-Strefa S.A.
  • Novo Nordisk A/S
  • Owen Mumford, Ltd.
  • MORE
1 Introduction
1.1 Objectives Of The Study
1.2 Market Scope
1.3 Markets Covered
1.4 Stakeholders
1.5 Limitations

2 Research Methodology
2.1 Secondary And Primary Research Methodology
2.1.1 Secondary Research
2.1.2 Key Data From Secondary Sources
2.1.3 Primary Research
2.1.4 Key Industry Insights
2.1.4.1 Supply Side
2.1.4.2 Demand Side
2.1.5 Key Data From Primary Sources
2.1.6 Key Insights From Primary Sources
2.1.7 Market Size Estimation Methodology
2.1.8 Market Forecast Methodology
2.1.9 Market Data Validation And Data Triangulation
2.1.10 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Asia To Be The Fastest-Growing Region In The Pen Needles Market
4.2 Pen Needles Market, By Region And Therapy
4.3 Geographical Snapshot
4.4 Pen Needles Market, By Type

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Favorable Reimbursement Environment In North America & Europe
5.3.1.2 Strong Government Support In The Pacific
5.3.1.3 Advantages Of Insulin Pens Over Syringes And Vials
5.3.1.4 Technological Advancements
5.3.1.5 Entry Of Companies Into The Pen Needles Market
5.3.1.6 Growing Diabetic Population
5.3.1.7 Awareness Campaigns/Conferences
5.3.2 Restraints
5.3.2.1 Poor Reimbursement Structure In Developing Countries
5.3.2.2 Needle Anxiety
5.3.2.3 Severe Shortage Of Endocrinologists In The U.S.
5.3.3 Threats
5.3.3.1 Risk Involved In Reusing Needles
5.3.3.2 Alternative Drug Delivery Methods
5.3.4 Opportunities
5.3.4.1 Safety Needles
5.3.4.2 Glp-1 Analogs
5.3.5 Challenges
5.3.5.1 Minimizing The Reuse Of Standard Pen Needle
5.3.5.2 Conservatism Towards Adoption Of Pen Injectors
5.3.6 Trends
5.3.6.1 Shorter & Higher-Gauge Needles
5.3.6.2 Easy-To-Fit Needles

6 Industry Insights
6.1 Porter’s Five Forces Analysis
6.1.1 Threat Of New Entrants
6.1.2 Supplier’s Bargaining Power
6.1.3 Buyer’s Bargaining Power
6.1.4 Segment Rivalry
6.1.5 Threat Of Substitutes
6.2 Competitive Intensity
6.2.1 Evaluation Parameters And Scores
6.2.2 Scoring Methodology
6.2.3 Competitive Intensity Score, By Company
6.2.3.1 Competitive Intensity Score For Bd
6.2.3.1 Competitive Intensity Score For Novo Nordisk
6.2.3.2 Competitive Intensity Score For Ypsomed
6.2.4 Competitive Intensity Mapping Of Bd, Novo Nordisk, And Ypsomed
6.2.5 Comparison Of Evaluation Parameters,By Company
6.2.5.1 Pricing
6.2.5.2 Product Portfolio
6.2.5.3 Product Launches/Technological Advancements
6.2.5.4 Production Capacity (2013)
6.2.5.5 Geographic Presence
6.2.5.6 Promotional/Marketing Activities
6.2.5.7 Sponsorship/Donations/Education/Awareness Campaigns
6.2.5.8 M&A, Partnerships, Collaborations, Agreements, And Expansion
6.2.5.9 Years Of Experience
6.2.5.10 Certifications/Accreditations/Awards
6.3 Empirical Assessment Of Growth Strategies
6.3.1 Route To Strategic Growth: Organic And Inorganic Growth Strategies
6.3.2 Organic Growth Strategies
6.3.3 Inorganic Growth Strategies

7 Pen Needles Market, By Type
7.1 Introduction
7.2 Standard Pen Needles
7.3 Safety Pen Needles

8 Pen Needles Market, By Length
8.1 Introduction

9 Pen Needles Market, By Therapy
9.1 Introduction
9.2 Insulin
9.3 Glucagon-Like Peptide-1 (Glp-1)
9.4 Growth Hormones

10 Pen Needles Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Growing Diabetes Prevalence Coupled With Reimbursement For Pen Needle To Boost Market
10.2.1.2 Federal Initiatives To Create Awareness About Injection Techniques To Stimulate U.S. Market
10.2.1.3 Increasing Activities Of Leading Players To Penetrate The U.S. Market To Push The Sales In The Region
10.2.1.4 Improved Pen Needle Technologies To Eliminate Needlestick Injuries To Fuel Market Growth
10.2.1.5 Low Penetration Of Pen Injectors In U.S. As Compared To Europe
10.2.2 Canada
10.2.2.1 High Diabetes Prevalence And Reimbursement For Pen Needle To Boost Market
10.2.2.2 Government Support In Alberta To Increase Usage Of Pen Needle In The Region
10.3 Europe
10.3.1 Germany
10.3.1.1 Regulatory Framework To Minimize Needlestick Injuries & Boost Use Of Safety-Engineered Devices
10.3.1.2 High Diabetes Prevalence And Reimbursement For Pen Needle To Accelerate German Market
10.3.2 U.K.
10.3.2.1 Activities To Pool Funds For Diabetes Care & Research To Stimulate Use Of Needles
10.3.3 France
10.3.3.1 Conferences And Exhibitions To Increase Exposure For Pen Needle Players In French Market
10.3.3.2 Higher Insurance Coverage, Increase In Aging Population And Affordability Driving Market In France
10.3.4 Italy
10.3.4.1 Wide Regional Variations In Terms Of Benefits And Coverage To Drive Slow Growth In Italy
10.3.4.2 Awareness Campaigns For Diabetes In Italy To Propel The Market Growth
10.3.5 Spain
10.3.5.1 Spain Is Amongst The Top 10 Countries With Highest Expenditure On Diabetes
10.3.5.2 Spain Is Highly Active In Terms Of Exports Of Injectable Drug Delivery Devices
10.3.6 Rest Of Europe
10.3.6.1 High Diabetes Prevalence In Russia, Turkey, Poland, Romania, And Ukraine To Propel The Market For Pen Needle
10.4 Asia
10.4.1 Japan
10.4.1.1 High Adoption Of Insulin Pens And Approval Of Injectable Insulin To Fuel Market
10.4.2 China
10.4.2.1 Growing Presence Of Global Players In China To Boost The Market
10.4.2.2 High Diabetes Incidence And Adoption Of Insulin Pens To Stimulate The Market In China
10.4.2.3 Low Penetration Of Insulin Pens, High Re-Usage Rate & Lack Of Reimbursement To Limit Market Growth
10.4.3 India
10.4.3.1 Growing Presence Of Global Players In India To Propel The Market
10.4.3.2 Rising Diabetes Incidence To Stimulate The Market In India
10.4.4 Rest Of Asia
10.4.4.1 Vietnam A Potential Market For Pen Needle
10.4.4.2 Singapore & Malaysia Likely To Showcase Increase In Adoption Of Market
10.5 Rest Of The World (RoW)
10.5.1 Latin America
10.5.2 Pacific Countries
10.5.3 Middle East & Africa

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.2.1 Introduction
11.2.1.1 Becton, Dickinson And Company (U.S.)
11.2.1.2 Novo Nordisk A/S (Denmark)
11.2.1.3 Ypsomed Holding Ag (Switzerland)
11.2.1.4 Others
11.3 Competitive Situation And Trends
11.3.1 Expansions
11.3.2 New Product Launches
11.3.3 Acquisitions
11.3.4 Others

12 Company Profiles
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 Becton, Dickinson And Company
12.2 Novo Nordisk A/S
12.3 Ypsomed Holding Ag
12.4 Allison Medical, Inc.
12.5 Artsana S.P.A.
12.6 B. Braun Melsungen
12.7 Htl-Strefa S.A.
12.8 Owen Mumford, Ltd.
12.9 Terumo Corporation
12.10 Ultimed, Inc.
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

13 Appendix
13.1 Discussion Guide
13.2 Introducing Rt: Real-Time Market Intelligence
13.3 Available Customizations
13.4 Related Reports

List of Tables (104 Tables)

Table 1 Emergence Of Several Local Pen Needle Manufacturers And Suppliers Is Observed Worldwide
Table 2 Favorable Reimbursement Environment In North America & Europe Propelling The Growth Of Market
Table 3 Poor Reimbursement Structure In Developing Countries Is Restraining The Growth Of Market
Table 4 Risk Involved In Reuse Of Pen Needle A Major Threat To Pen Needles Market
Table 5 Safety Needles Provide Greatest Potential For Pen Needles Market
Table 6 Minimizing Reuse Of Standard Pen Needle A Major Challenge
Table 7 Growing Trend Of Adoption Of Needles With Shorter Lengths & Higher Gauges
Table 8 Evaluation Parameters And Scores
Table 9 Competitive Intensity For Bd
Table 10 Competitive Intensity For Novo Nordisk
Table 11 Competitive Intensity For Ypsomed
Table 12 Market Size, By Type, 2012–2019 ($Million)
Table 13 Market Size, By Type, 2012–2019 (Million Units)
Table 14 Standard Pen Needles Market Size, By Region, 2012–2019 ($Million)
Table 15 Standard Pen Needles Market Size, By Region, 2012–2019 (Million Units)
Table 16 North America: Standard Pen Needles Market Size, By Country, 2012–2019 ($Million) 72
Table 17 North America: Standard Pen Needles Market Size, By Country, 2012–2019 (Million Units) 73
Table 18 Europe: Standard Pen Needles Market Size, By Country, 2012–2019 ($Million) 73
Table 19 Europe: Standard Pen Needles Market Size, By Country, 2012–2019 (Million Units) 74
Table 20 Asia: Standard Pen Needles Market Size, By Country, 2012–2019 ($Million) 74
Table 21 Asia: Standard Pen Needles Market Size, By Country, 2012–2019 (Million Units) 74
Table 22 RoW: Standard Pen Needles Market Size, By Region, 2012–2019 ($Million) 75
Table 23 RoW: Standard Pen Needles Market Size, By Region, 2012–2019 (Million Units) 75
Table 24 Safety Pen Needles Market Size, By Region, 2012–2019 ($Million)
Table 25 Safety Pen Needles Market Size, By Region, 2012–2019 (Million Units)
Table 26 North America: Safety Pen Needles Market Size, By Country, 2012–2019 ($Million) 77
Table 27 North America: Safety Pen Needles Market Size, By Country, 2012–2019 (Million Units) 77
Table 28 Europe: Safety Pen Needles Market Size, By Country, 2012–2019 ($Million) 77
Table 29 Europe: Safety Pen Needles Market Size, By Country, 2012–2019 (Thousand Units) 78
Table 30 Asia: Safety Pen Needles Market Size, By Country, 2012–2019 ($Million)
Table 31 Asia: Safety Pen Needles Market Size, By Country, 2012–2019 (Million Units) 78
Table 32 RoW: Safety Pen Needles Market Size, By Region, 2012–2019 ($Million)
Table 33 RoW: Safety Pen Needles Market Size, By Country, 2012–2019 (Thousand Units) 79
Table 34 Pen Needles Market Size, By Length, 2012–2019 ($Million)
Table 35 North America: Market Size, By Length, 2012–2019 ($Million) 82
Table 36 Europe: Market Size, By Length, 2012–2019 ($Million)
Table 37 Asia: Market Size, By Length, 2012–2019 ($Million)
Table 38 RoW: Market Size, By Length, 2012–2019 ($Million)
Table 39 Pen Needles Market Size, By Therapy, 2012–2019 ($Million)
Table 40 Insulin Market Size, By Region, 2012–2019 ($Million)
Table 41 Glp-1 Market Size, By Region, 2012–2019 ($Million)
Table 42 Growth Hormones Market Size, By Region, 2012–2019 ($Million)
Table 43 Pen Needles Market Size, By Region, 2012–2019 ($Million)
Table 44 Pen Needles Market Size, By Region, 2012–2019 (Million Units)
Table 45 North America: Market Size, By Type, 2012–2019 ($Million)
Table 46 North America: Market Size, By Type, 2012–2019 (Million Units)
Table 47 North America: Market Size, By Country, 2012–2019 ($Million) 94
Table 48 North America: Market Size, By Country, 2012–2019 (Million Units) 94
Table 49 North America: Market Size, By Therapy, 2012–2019 ($Million) 95
Table 50 Estimated Cost Savings From The Use Of Safety-Engineered Devices In The U.S.
Table 51 U.S.: Market Size, By Type, 2012–2019 ($Million)
Table 52 U.S.: Market Size, By Type, 2012–2019 (Million Units)
Table 53 Canada: Market Size, By Type, 2012–2019 ($Million)
Table 54 Canada: Market Size, By Type, 2012–2019 (Million Units)
Table 55 Europe: Market Size, By Type, 2012–2019 ($Million)
Table 56 Europe: Market Size, By Type, 2012–2019 (Million Units)
Table 57 Europe: Market Size, By Country, 2012–2019 ($Million)
Table 58 Europe: Market Size, By Country, 2012–2019 (Million Units)
Table 59 Europe: Market Size, By Therapy, 2012–2019 ($Million)
Table 60 Estimated Annual Number Of Infection Caused By Nsis In German Hospitals
Table 61 Germany: Market Size, By Type, 2012–2019 ($Million)
Table 62 Germany: Market Size, By Type, 2012–2019 (Million Units)
Table 63 Highlights Of Diabetes U.K. Activities, 2013
Table 64 U.K.: Market Size, By Type, 2012–2019 ($Million)
Table 65 U.K.: Market Size, By Type, 2012–2019 (Million Units)
Table 66 France: Market Size, By Type, 2012–2019 ($Million)
Table 67 France: Market Size, By Type, 2012–2019 (Million Units)
Table 68 Campaign Highlights:
Table 69 Italy: Market Size, By Type, 2012–2019 ($Million)
Table 70 Italy: Market Size, By Type, 2012–2019 (Million Units)
Table 71 Spain: Market Size, By Type, 2012–2019 ($Million)
Table 72 Spain: Market Size, By Type, 2012–2019 (Million Units)
Table 73 RoE: Market Size, By Type, 2012–2019 ($Million)
Table 74 RoE: Market Size, By Type, 2012–2019 (Million Units)
Table 75 Asia: Market Size, By Type, 2012–2019 ($Million)
Table 76 Asia: Market Size, By Type, 2012–2019 (Million Units)
Table 77 Asia: Market Size, By Country, 2012–2019 ($Million)
Table 78 Asia: Market Size, By Country, 2012–2019 (Million Units)
Table 79 Asia: Market Size, By Therapy, 2012–2019 ($Million)
Table 80 Japan: Market Size, By Type, 2012–2019 ($Million)
Table 81 Japan: Market Size, By Type, 2012–2019 (Million Units)
Table 82 China: Market Size, By Type, 2012–2019 ($Million)
Table 83 China: Market Size, By Type, 2012–2019 (Million Units)
Table 84 India: Market Size, By Type, 2012–2019 ($Million)
Table 85 India: Market Size, By Type, 2012–2019 (Million Units)
Table 86 RoA: Market Size, By Type, 2012–2019 ($Million)
Table 87 RoA: Market Size, By Type, 2012–2019 (Million Units)
Table 88 RoW: Market Size, By Type, 2012–2019 ($Million)
Table 89 RoW: Market Size, By Type, 2012–2019 (Million Units)
Table 90 RoW: Market Size, By Country, 2012–2019 ($Million)
Table 91 RoW: Market Size, By Country, 2012–2019 (Million Units)
Table 92 RoW: Market Size, By Therapy, 2012–2019 ($Million)
Table 93 Latin America: Market Size, By Type, 2012–2019 ($Million)
Table 94 Latin America: Market Size, By Type, 2012–2019 (Thousand Units) 124
Table 95 Pacific Countries: Market Size, By Type, 2012–2019 ($Million) 124
Table 96 Pacific Countries: Market Size, By Type, 2012–2019 (Thousand Units) 124
Table 97 Middle East & Africa: Market Size, By Type, 2012–2019 ($Million) 125
Table 98 Middle East & Africa: Market Size, By Type, 2012–2019 (Thousand Units) 125
Table 99 Bd, 2013 Awards, Recognitions, And Affiliations
Table 100 Ypsomed’s Statistics On Pipeline Of Insulin Pens As Of 2013
Table 101 Expansions, 2011–2014
Table 102 New Product Launches, 2011–2013
Table 103 Acquisitions, 2011–2014
Table 104 Others, 2011–2014

List of Figures (62 Figures)

Figure 1 Research Methodology Steps
Figure 2 Sampling Frame: Primary Research
Figure 3 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Market Forecast Methodology
Figure 7 Data Triangulation Methodology
Figure 8 Market Snapshot, 2014–2019
Figure 9 Safety Needles Market To Witness Highest Cagr Of 13.4% In Forecast Period
Figure 10 Market For 4mm Pen Needles To Witness Highest Growth From 2014 To 2019
Figure 11 Market Share, 2014
Figure 12 Market Overview
Figure 13 Europe Dominates The Pen Needles Market In 2014
Figure 14 Asia To Grow At The Fastest Rate During The Forecast Period
Figure 15 Standard Pen Needles Account For The Highest Share Of The Market, By Type
Figure 16 Market Segmentation
Figure 17 Market Dynamics
Figure 18 Top 10 Countries/Territories For Number Of People With Diabetes (20–79 Years), 2013 And 2035 38
Figure 19 Porter’s Five Forces Analysis
Figure 20 Scoring Methodology
Figure 21 Comparison Of Competitive Intensity Scores: Bd, Novo Nordisk, And Ypsomed
Figure 22 Relative Positioning Of Companies Based On Competitive Intensity Score And Pen Needle Focus
Figure 23 Safety Pen Needles By Bd And Standard Pen Needles By Novo Nordisk Are Premium-Priced
Figure 24 Bd Has Robust Portfolio Of Both Standard And Safety Pen Needles
Figure 25 Bd Has High Focus On Innovation In Its Pen Needles Business
Figure 26 Bd Has Highest Production Capacity Of Pen Needles
Figure 27 Bd And Novo Nordisk Have Strong Geographic Presence
Figure 28 Bd And Novo Nordisk Showcase High Focus On Marketing And Promotional Activities
Figure 29 Novo Nordisk Has High Focus On Diabetes Education And Awareness
Figure 30 Novo Nordisk Aggressively Follows Partnerships, Collaborations, Agreements, And Expansions
Figure 31 Novo Nordisk, A Pioneer In Pen Needles Is Most Experienced Firm In Pen Needles Market
Figure 32 Bd, Novo Nordisk, And Ypsomed Equally Exhibit High Compliance With Industry Standards
Figure 33 Organic And Inorganic Growth Strategies
Figure 34 Organic Growth Strategies, By Key Players (2011–2014)
Figure 35 Inorganic Growth Strategies, By Key Players (2011–2014)
Figure 36 Standard Pen Needles To Command Larger Share Of The Market In 2014
Figure 37 Market For Safety Pen Needles To Grow At The Highest Cagr From 2014 To 2019 69
Figure 38 Indicative List Of Key Players (Manufacturers/Marketers) In Global Market
Figure 39 Indicative List Of Players (Manufacturers/Marketers) In Pen Needles Market In Specific Countries
Figure 40 6mm Pen Needles Segment To Command The Largest Share Of Market In 2014
Figure 41 Insulin Therapy Segment To Command Largest Share Of Market In 2014
Figure 42 Europe To Command Largest Share Of The Global Market
Figure 43 U.S. Will Be Fastest-Growing Segment Of North American Market
Figure 44 Germany To Be The Fastest-Growing Country Of Pen Needles Market In Europe
Figure 45 Diabetes U.K. Works To Improve Quality Of Life Of Diabetic Population
Figure 46 In 2012, Russia Had The Highest Diabetes Cases Of 12.7 Million Cases In Europe
Figure 47 China Is The Fastest Growing Pen Needles Market In Asia
Figure 48 Row To Account For A 10.5% Share Of The Global Market In 2014
Figure 49 Companies Adopted Expansions Key Growth Strategy In Last Three Years
Figure 50 Market Share Analysis, By Key Player, 2013
Figure 51 Battle For Market Share: Expansion Was The Key Strategy
Figure 52 Diabetes Care Revenue Mix And Product Protfolio Comparison Of Top Three Players
Figure 53 Company Snapshot
Figure 54 Company Snapshot
Figure 55 Company Snapshot
Figure 56 Company Snapshot
Figure 57 Company Snapshot
Figure 58 Company Snapshot
Figure 59 Company Snapshot
Figure 60 Company Snapshot
Figure 61 Company Snapshot
Figure 62 Company Snapshot
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
- Allison Medical, Inc.
- Artsana S.P.A.
- B. Braun Melsungen
- Becton, Dickinson And Company
- Htl-Strefa S.A.
- Novo Nordisk A/S
- Owen Mumford, Ltd.
- Terumo Corporation
- Ultimed, Inc.
- Ypsomed Holding Ag
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll